Skip to main content
. 2023 Nov 2;8:96. Originally published 2023 Feb 22. [Version 2] doi: 10.12688/wellcomeopenres.17995.2

Figure 2. Predicted SARs for each combination of vaccine status of case and contact.

Figure 2.

Large numbers inside cells are the median SAR of the posterior distribution, with the small numbers below and above corresponding to the 95% credible interval. SAR, secondary attack rate; BNT162b2, Pfizer-BioNTech mRNA vaccine; ChAdOx1, Oxford AstraZeneca adenovirus vector vaccine.